kratom FDA

NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status

Leave a Comment / Current Events, General, News, Research / By

On June 1, the National Institutes of Health (NIH) announced that mitragynine, the most abundant alkaloid in kratom, has been cleared as an Investigational New Drug (IND). With IND status, scientists at University of Florida are now authorized to study the effects of pure mitragynine in human subjects. National Institute on Drug Abuse (NIDA) Director …

NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status Read More »

FDA Study on Kratom Published

2 Comments / General, News, Research / By

A long-awaited kratom clinical study conducted by the U.S. Food and Drug Administration (FDA) has been published in the Journal of Clinical Psychopharmacology. The pilot study (defined as “a preliminary investigation designed to test the feasibility and design of a larger, more comprehensive study”) involved healthy adult participants who were administered an ascending dose of …

FDA Study on Kratom Published Read More »

Scientists find “insufficient evidence to suggest that kratom causes seizures”

Leave a Comment / General, Research / By

Note: There is a correlation between kratom and seizures, but causation has not been established. Kratom alone or kratom combined with other substances could very well cause seizures in some consumers, but as this study shows, there is not enough evidence to determine causation. Seizures have been commonly listed as a side effect of kratom …

Scientists find “insufficient evidence to suggest that kratom causes seizures” Read More »